[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"MED-EL Elektromedizinische Geräte GesmbH\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":263},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,42,72,91,113,138,159,182,214,236],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100053617","retrospectively-investigating-longitudinal-outcomes-in-med-el-sonata-2-cochlear-implant-recipients-100053617",false,"NCT07697911","Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients.","Longitudinal Outcomes of SONATA 2 Cochlear Implant Recipients: a Retrospective Study","LORIS","Inclusion Criteria:\n\n* At least one MED-EL SONATA 2 cochlear implant with a compatible MED-EL audio processor\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criteria","ALL",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.\n\nHowever, there is only few evidence from large long-term observational studies available to gain knowledge on clinical effectiveness of cochlear implants. With continued pressure on healthcare system budgets, there is an increasing demand for evidence-based research that demonstrates an intervention is effective in the real-world environment across large and diverse populations. Currently, there is a paucity of data concerning the long-term outcomes of subjects implanted with a SONATA 2 cochlear implant from representative samples of the population. This retrospective study aims at analyzing SONATA 2 cochlear implant data from clinical routine.",[24,25,26],"Cochlear Implant","SONATA 2","Cochlear Implantation",[28],"retrospective data collection","NOT_YET_RECRUITING","2026-07-06",{"date":32,"type":33},"2026-07-13","ACTUAL",{"date":35,"type":20},"2026-09",{"date":37,"type":20},"2027-05",{"name":39,"class":40},"MED-EL Elektromedizinische Geräte GesmbH","INDUSTRY",2,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},"100572739","comparison-of-speech-understanding-between-tonotopy-based-fitting-and-setting-based-on-evolutionary-algorithms-100572739","NCT06737185","Comparison of Speech Understanding Between Tonotopy-based Fitting and Setting Based on Evolutionary Algorithms","Comparison of Speech Understanding Between Tonotopy-based Fitting and Evolutionary Algorithm-based Setting: a Prospective Cross-sectional Study","Inclusion Criteria:\n\n* Adult patient (\\>= 18 years old) speaking French\n* Patient who fulfils the criteria for cochlear implantation\n\nExclusion Criteria:\n\n* retro-cochlear pathology: auditory neuropathy, vestibular schwannoma","18 Years",{"count":51,"type":20},22,"INTERVENTIONAL",[54],"NA","Main objective:\n\nCompare speech recognition in noise with tonotopic setting (FS4T) and with tonotopic fitting modified by evolutionary algorithm (EAFS4T) in adult patients implanted for 6 months or more with a MED-EL cochlear implant with FS4T.\n\nSecondary objectives:\n\nComparison of FS4T and EAFS4T settings\n\n* for speech recognition in quiet\n* for subjective auditory spatial perception\n* for subjective auditory and musical perception",[57],"Sensorineural Hearing Loss, Bilateral",[59,60,61],"cochlear implant","evolutionary algorithms","tonotopy-based fitting","RECRUITING","2026-04-30",{"date":65,"type":33},"2026-05-06",{"date":67,"type":33},"2025-01-15",{"date":69,"type":20},"2028-01-15",{"name":39,"class":40},1,{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":52,"phases":80,"briefSummary":81,"conditions":82,"keywords":83,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":85,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":71},"100571669","speech-perception-of-a-tonotopy-based-fitting-for-cochlear-implant-recipients-for-6-months-with-conventional-setting-100571669","NCT06723262","Speech Perception of a Tonotopy-based Fitting for Cochlear Implant Recipients for 6 Months With Conventional Setting","Contribution to Speech Perception of a Tonotopy-based Fitting for Patients With Cochlear Implants for 6 Months With a Conventional Setting: Prospective Cross-sectional Study",{"count":79,"type":20},25,[54],"Main objective:\n\nCompare speech recognition in noise with tonotopic fitting (FS4T) and with conventional non-tonotopic fitting (FS4noT) in adult patients implanted for 6 months with a MED-EL cochlear implant with FS4noT strategy.\n\nSecondary objectives:\n\nComparison of FS4noT and FS4T settings\n\n* for speech recognition in quiet\n* for subjective auditory spatial perception",[57],[84],"cochlear implant strategy anatomy-based fitting",{"date":65,"type":33},{"date":87,"type":33},"2025-01-01",{"date":89,"type":20},"2028-06-30",{"name":39,"class":40},{"id":92,"slug":93,"hasResults":11,"nctId":94,"briefTitle":95,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":98,"targetDuration":100,"studyType":21,"phases":4,"briefSummary":101,"conditions":102,"keywords":4,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},"100490608","med-el-hearing-solutions-mehs-an-observational-study-100490608","NCT05668338","MED-EL HEARING SOLUTIONS (MEHS): AN OBSERVATIONAL STUDY","MEHS","Inclusion Criteria:\n\n* For children and adults receiving an implant: Subjects submitted or planned to be submitted to unilateral or bilateral implantation, using simultaneous or sequential procedures.\n* For children and adults receiving a non-implantable device: Subjects submitted or planned to be submitted to unilateral or bilateral treatment with a non-implantable device from MED-EL.\n* Unilateral, bilateral or bimodal users (children and adults) of cochlear implants (CIs), electric-acoustic devices, bone conduction implants, middle ear implants or any other implantable or non-implantable hearing solution from MED-EL.\n* Signed written informed consent for data collection for Registry purposes.\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criteria.\n* Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the Registry procedures",{"count":99,"type":20},100,"5 Years","This Registry represents a non-interventional systematic collection of clinical data in which prospective data from children and adults are collected as fully anonymized data sets, derived from original clinical records on appropriately informed subjects.\n\nThis is a patient-outcomes Registry for subjects of any age who are provided in routine clinical practice with one or more MED-EL hearing devices. The Registry aims to collect data for hypothesis generation on subject device use, auditory performance, quality of life and health-related utilities, across different types of implantable and non-implantable hearing devices from MED-EL company. Subjects will be evaluated with a set of standardized tests and questionnaires prior to implantation or prior to initial device activation (baseline) and at follow-up intervals according to the clinical practice.",[103],"Hearing Loss","2026-02-17",{"date":106,"type":33},"2026-02-19",{"date":108,"type":33},"2017-06-26",{"date":110,"type":20},"2030-12",{"name":39,"class":40},8,{"id":114,"slug":115,"hasResults":11,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":4,"eligibilityCriteria":119,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":120,"targetDuration":4,"studyType":52,"phases":122,"briefSummary":123,"conditions":124,"keywords":126,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":71},"100512670","comparison-in-new-cochlear-implanted-subjects-of-a-tonotopy-based-bimodal-fitting-and-a-conventional-fitting-100512670","NCT05955469","Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting and a Conventional Fitting","Comparison of Speech Understanding Between a Tonotopy-based Bimodal Fitting and a Default Bimodal Fitting in Newly Cochlear-implanted Patients: a Double-blind Randomized Crossover Study.","Inclusion Criteria:\n\n* Adult patient (\\>= 18 years old) speaking French\n* Patient who fulfils the criteria for cochlear implantation\n\nExclusion Criteria:\n\n* retro-cochlear pathology: auditory neuropathy, vestibular schwannoma\n* patient with residual hearing \\\u003C 70 dB hearing level (HL) at 500 Hz and 1000 Hz on the contralateral ear",{"count":121,"type":20},20,[54],"Main objective:\n\nFor a bimodal fitting (hearing aid (HA) + cochlear implant (CI)): Comparison of a tonotopy based fitting strategy (TFS4) to a default fitting strategy (FS4) for the speech recognition in noise.\n\nSecondary objectives:\n\nComparison of TFS4 to FS4 for speech recognition in quiet. Comparison of TFS4 to FS4 for the auditory skills experienced by the subject.",[57,125],"Bilateral Hearing Loss",[127,128,129],"Cochlear implant","Bimodal fitting","Anatomy-based fitting","2026-01-16",{"date":132,"type":33},"2026-01-20",{"date":134,"type":33},"2024-11-05",{"date":136,"type":20},"2027-01-01",{"name":39,"class":40},{"id":139,"slug":140,"hasResults":11,"nctId":141,"briefTitle":142,"officialTitle":143,"acronym":4,"eligibilityCriteria":144,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":145,"targetDuration":4,"studyType":52,"phases":146,"briefSummary":147,"conditions":148,"keywords":149,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":154,"completionDateStruct":156,"leadSponsor":158,"locationsCount":71},"100508303","comparison-in-new-cochlear-implanted-subjects-of-a-tonotopy-based-bimodal-fitting-with-or-without-synchronization-100508303","NCT05898659","Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting With or Without Synchronization","Comparison of a Bimodal Fitting With Synchronization and a Conventional Bimodal Fitting in Newly Implanted Cochlear Patient. Prospective Monocentric Randomized Double-blind Crossover Study.","Inclusion Criteria:\n\n* Adult patient (\\>= 18 years old) speaking French\n* Patient who fulfils the criteria for cochlear implantation\n* Total hearing loss for less than 5 years\n\nExclusion Criteria:\n\n* retro-cochlear pathology: auditory neuropathy, vestibular schwannoma\n* patient with residual hearing \\\u003C 70 dB hearing level (HL) at 250 Hz and 500 Hz and \\\u003C 80 dB HL at 1000 Hz on the contralateral ear",{"count":121,"type":20},[54],"Main objective:\n\nFor a bimodal fitting (hearing aid (HA) + cochlear implant (CI)): Comparison of a tonotopy based fitting strategy with synchronization between HA and CI (ABFS) to a tonotopy based fitting strategy without synchronization (ABFnoS) for the accuracy of sound localization.\n\nSecondary objectives:\n\nComparison of ABFS to ABFnoS for the bias of sound localization. Comparison of ABFS to ABFnoS for speech perception in noise. Comparison of ABFS to ABFnoS for the auditory skills experienced by the subject.",[57],[59,150,61],"bimodal fitting","2026-01-12",{"date":153,"type":33},"2026-01-14",{"date":155,"type":33},"2023-10-17",{"date":157,"type":20},"2026-12-15",{"name":39,"class":40},{"id":160,"slug":161,"hasResults":11,"nctId":162,"briefTitle":163,"officialTitle":164,"acronym":4,"eligibilityCriteria":165,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":166,"targetDuration":4,"studyType":52,"phases":168,"briefSummary":169,"conditions":170,"keywords":171,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":174,"lastUpdatePostDateStruct":175,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":181,"locationsCount":71},"100407873","auditory-performances-with-different-stimulation-depths-in-cochlear-implanted-subjects-using-a-fine-structure-strategy-100407873","NCT04591093","Auditory Performances With Different Stimulation Depths in Cochlear Implanted Subjects Using a Fine Structure Strategy","Study of Musical Perception and Post-operative Auditory Performance as a Function of the Depth of Stimulation in Subjects Implanted With a MED-EL Cochlear Implant and Using a FineHearing Strategy Single-center Randomized Cross-over Study","Inclusion Criteria:\n\n* Adult patient (≥ 18 years old) speaking French\n* Patient who fulfils the criteria for cochlear implantation\n* Patient with a postoperative insertion angle of the apical electrode \\> 450°\n* Patient with 12 active electrodes on the day of activation.\n\nExclusion Criteria:\n\n* Retro-cochlear pathology: auditory neuropathy, vestibular schwannoma",{"count":167,"type":20},32,[54],"Main objective:\n\nInvestigate on new cochlear implanted patients whether the FineHearing strategy of the MED-EL cochlear implant gives better results on musical perception if the depth of stimulation (stimulation or not of the apical areas) is greater.\n\nSecondary objectives:\n\nEvaluate the effect of stimulation depth on vocal audiometric results, results of differential frequency threshold test and on qualitative sound perception.",[57],[59,172,173],"stimulation strategy","sound coding strategy","2025-11-18",{"date":176,"type":33},"2025-11-19",{"date":178,"type":33},"2021-07-10",{"date":180,"type":20},"2026-09-30",{"name":39,"class":40},{"id":183,"slug":184,"hasResults":11,"nctId":185,"briefTitle":186,"officialTitle":187,"acronym":188,"eligibilityCriteria":189,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":190,"enrollmentInfo":191,"targetDuration":4,"studyType":52,"phases":193,"briefSummary":194,"conditions":195,"keywords":198,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":205,"lastUpdatePostDateStruct":206,"startDateStruct":208,"completionDateStruct":210,"leadSponsor":212,"locationsCount":213},"100600521","comparison-of-four-channel-functional-electrical-stimulation-vs-one-channel-electrical-stimulation-on-moderate-armhand-paresis-in-subacute-stroke-patients-100600521","NCT07098572","Comparison of Four-Channel Functional Electrical Stimulation vs. One-Channel Electrical Stimulation on Moderate Arm\u002FHand Paresis in Subacute Stroke Patients","Efficacy of EMG-triggered Four-Channel Functional Electrical Stimulation vs. Cyclic One-Channel Electrical Stimulation on Moderate Arm\u002FHand Paresis in Subacute Stroke Patients. A Randomized Controlled Single Blinded Multicenter Study","MKES2","Inclusion Criteria:\n\n* First-time ischemic stroke with moderate arm paresis (Motricity Index - UE Sum-Score ≥ 40 ≤ 77 points) (Collin \\& Wade, 1990)\n* Early to late subacute phase (7 days - 6 months) (Bernhardt et al., 2017)\n* Existing ADL ability before the event (ICF d5 self-care, d6 domestic life, extent of problem ≤1 points) (WHO, 2001)\n* Age ≥18 - 99 years\n* Signed and dated ICF before the start of any study-specific procedure.\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criteria\n* Implanted defibrillators, brain stimulators, pacemakers, medication pumps\n* Therapy-resistant epilepsy\n* Fever or infectious diseases\n* Inflammatory or tumorous skin diseases in the stimulation area,\n* Thromboses or vein inflammations\n* Severe contractures of the affected extremity\n* Wounds in the stimulation area\n* Pregnancy\n* Known allergic reactions to components of the investigational medical device\n* Unstable psychological status\n* Participation in other pharmacological clinical investigations within four weeks prior to enrolment\n* Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study","99 Years",{"count":192,"type":20},44,[54],"This study will compare two treatments that may help participants recover after having suffered from stroke. Persons who experience weakness or paralysis of their arms\u002Fhands will be randomly placed in one of two groups. Each receives treatment five times a week for three weeks. One group will be treated with electrostimulation following a cyclic pattern (control treatment), the other group will be treated with electrostimulation triggered by nerve signals (i.e. stimulation starts when they deliberately try to move their arm (investigational treatment). Before and after the three weeks and additionally 12 weeks later, the ability to move the arm and hand will be documented with standardized tests.",[196,197],"Moderate Arm Paresis","Ischemic Stroke",[199,200,201,202,203,204],"Arm Paresis","Hand Paresis","Stiwell Profes","Electrostimulation","Ischemic stroke","Rehabilitation","2025-08-25",{"date":207,"type":33},"2025-08-26",{"date":209,"type":33},"2025-07-14",{"date":211,"type":20},"2028-01",{"name":39,"class":40},3,{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":218,"acronym":219,"eligibilityCriteria":220,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":221,"targetDuration":100,"studyType":21,"phases":4,"briefSummary":222,"conditions":223,"keywords":225,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":228,"lastUpdatePostDateStruct":229,"startDateStruct":231,"completionDateStruct":233,"leadSponsor":235,"locationsCount":213},"100353464","middle-east-med-el-observatory-study-100353464","NCT03882229","Middle East MED-EL Observatory Study","MEMOS","Inclusion Criteria:\n\n* Subjects who are implanted or will be implanted with a MED-EL CI system.\n* Signed written informed consent for data collection for registry purposes.\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criteria.\n* Subjects not receiving a MED-EL CI system due to medical or personal reasons after having consented.\n* Anything that, in the opinion of the Investigator would place the subject at increased risk or preclude the subject's full compliance with or completion of the registry procedures.",{"count":99,"type":20},"In the field of cochlear implant research, there are only few data on long-term observational studies available to gain knowledge on clinical effectiveness. Longitudinal comparisons of data collected in different clinics is challenging due to the heterogeneity in measures and procedure.\n\nThis Registry represents a non-interventional systematic collection of clinical data in which prospective data from children and adults are collected as anonymized data sets, derived from original clinical records on appropriately informed subjects. Each subject will be treated as per clinical routine.\n\nThe Registry will be implemented through a secure, cloud-based, platform that enables collection of anonymized data at consistent time intervals, thus enabling the comparison of repeated measures over time.",[224],"Cochlear Implants",[226,227],"Registry","Observational Study","2025-08-18",{"date":230,"type":33},"2025-08-19",{"date":232,"type":33},"2020-02-11",{"date":234,"type":20},"2030-01",{"name":39,"class":40},{"id":237,"slug":238,"hasResults":11,"nctId":239,"briefTitle":240,"officialTitle":241,"acronym":242,"eligibilityCriteria":243,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":244,"enrollmentInfo":245,"targetDuration":4,"studyType":52,"phases":247,"briefSummary":248,"conditions":249,"keywords":250,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":254,"lastUpdatePostDateStruct":255,"startDateStruct":257,"completionDateStruct":259,"leadSponsor":261,"locationsCount":262},"100527047","dexamethasone-eluting-cochlear-implant-a-pivotal-study-100527047","NCT06142682","Dexamethasone Eluting Cochlear Implant: a Pivotal Study","Dexamethasone-Eluting Cochlear Implant Electrode (CIDEXEL): Pivotal Study","CDEX2","Inclusion Criteria:\n\nMinimum age of eighteen (18) years at time of enrolment.\n\n* Hearing loss on the ipsilateral ear (see Figure 8 for the specific audiological criteria).\n* A functional auditory nerve in the ear to be implanted.\n* Subjects reporting to having used an optimally fit hearing aids for a minimum of three months before the decision that a cochlear implant is the preferential option.\n* Cochlea anatomy compatible with the insertion of a FLEX28 electrode array.\n* Compatibility with a soft surgery approach as per clinical practice at the site.\n* Post-lingual hearing impairment.\n* Subject fulfilling indication criteria for a CI according to the local professional standards, as reported by the implanting surgeon.\n* General health condition, psychological and emotional condition deemed compatible with the treatment and tests performed in this study and realistic expectations, as deemed appropriate by the implanting surgeon.\n* Signed and dated informed consent before the start of any study-specific procedure.\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criterion.\n* Previously having received a cochlear implant on the ear chosen for placing the IMD.\n* Evidence of ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array or might cause increased risk of infection (e.g. dysplastic cochlea), as confirmed by medical examination and\u002For as per CT\u002FMRT.\n* Evidence of anatomic abnormalities that would prevent appropriate placement of the stimulator housing in the bone of the skull.\n* Known allergic reaction or intolerance to the materials used in the implant (including medical grade silicone, platinum, iridium, parylene c, DEX).\n* Known absence of cochlear development or if the cause of deafness is non-functionality of the auditory nerve and\u002For the upper auditory pathway.\n* Evidence of active external or middle ear infection or history of recurrent middle ear infection in the ear to be implanted.\n* Evidence of perforated tympanic membrane in the ear to be implanted.\n* Patient reporting immunosuppressive therapy or corticosteroids therapy in the 4 weeks before enrolment.\n* Evidence of concomitant use of medicinal substances that, in the opinion of the investigator, could alter the therapeutic efficacy of dexamethasone.\n* Unwillingness or inability of the candidate to comply with all investigational requirements.\n* Evidence of medical contraindications to surgery of the middle and inner ear and anaesthesia.\n* Additional disabilities that would prevent or restrict participation in the audiological and medical evaluations required of the clinical investigation.\n* Subject not capable of giving consent.\n* Individual subjected to court-ordered or government-authorized deprivation of liberty as defined by § 27 MPDG.\n* Evidence of Pregnancy.","85 Years",{"count":246,"type":20},60,[54],"The newly developed MED-EL Cochlear Implant Mi1250 +FLEX28 DEX (CIDEXEL) incorporates the anti-inflammatory agent dexamethasone (DEX) into the electrode array. The passive elution of DEX during the post-implantation period has the purpose of counteracting the increase of the post-operative impedance induced by the insertion trauma.\n\nThe aim of this clinical investigation is to obtain confirmatory data concerning safety and performances of the investigational device in the clinical population.",[24],[251,252,253],"cochlear implantation","CI","Dexamethasone","2025-08-11",{"date":256,"type":33},"2025-08-12",{"date":258,"type":33},"2024-09-02",{"date":260,"type":20},"2026-05-30",{"name":39,"class":40},7,""]